Cancellation of state registration. Nantaride®

April 13, 2018
Active substances:
Trade names:
ICD-10:
V.F20-F29.F20    Schizophrenia
V.F20-F29.F21    Chrysotile disorder
V.F20-F29.F22    Chronic delusional disorders
V.F20-F29.F23    Acute and transient psychotic disorders
V.F20-F29.F25    Schizoaffective disorder
V.F20-F29.F29    Inorganic psychosis, unspecified
V.F30-F39.F30    Manic episode
V.F30-F39.F31    Bipolar affective disorder
Nantarid, quetipine, schizophrenia, schizophrenia, delusional disorders

Ministry of Health of the Russian Federation in accordance with Article32 of the Federal Law of 12.04.2010 No. 61-FZ "On the circulation of medicinal products" decided to abolish state registration and exclusion from the state register of medicinal products for the medical use of the medicinal product (registration certificate LSR-009347/09 dated 19.11.2009 issued by JSC " Gedeon Richter, Hungary):

Nantaride® (trade name of the medicinal product)

Quetiapine (international non-proprietary or grouping or chemical name)

film coated tablets, 25 mg 100 mg, 200 mg 300 mg (dosage form, dosage)

Gedeon Richter JSC, Hungary 1103 Gyomroi st. 19-21, Budapest, Hungary Joint Stock Company "GEDEON RICHTER-RUS" (JSC "GEDEON RICHTER-RUS"), Russia 140342, Moscow region, Egoryevsky district, pos. Shuvy, ul. Forestry, d. 40 (name and address of the location of the manufacturer of the medicinal product)

on the basis of a filing by an authorized legal entity of JSC Gedeon Richter, an application for the cancellation of the state registration of a medicinal product.